당뇨병 치료약제와 심혈관 질환
Anti-Diabetic Drugs in Cardiovascular Disease
- Resource Type
- Article
- Authors
- 김세은 / Se-eun Kim; 유병수 / Byung-su Yoo
- Source
- 대한내과학회지 (Korean J Med) / The Korean Journal of Medicine (Korean J Med). Apr 01, 2021 96(2):85
- Subject
- 당뇨 치료약제
안정성
심혈관 질환 발생 연구
Anti-diabetic drugs
Safety
Cardiovascular outcomes trials
- Language
- Korean
- ISSN
- 1738-9364
Diabetes is one of the important risk factors in cardiovascular disease associated with atherosclerosis, and cardiovascular disease is the leading cause of death in patients with diabetes mellitus. Recent randomized placebo-controlled cardiovascular outcome trials of all new antidiabetic drugs have linked SGLT-2 inhibitors and GLP1-agonists to not only increased cardiovascular stability but significant reduction of cardiovascular disease. These results have led to preferential selection of the most effective and beneficial antidiabetic drugs with the evidence of cardiovascular safety and efficacy. Herein, we address cardiovascular stability and the effectiveness of antidiabetic drugs, focusing on recently developed ones. (Korean J Med 2021;96:85-91)